A5032593836- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis C virus research
- Organ Transplantation Techniques and Outcomes
- Ultrasound and Hyperthermia Applications
- Colorectal Cancer Treatments and Studies
- Hepatitis B Virus Studies
- Pancreatic and Hepatic Oncology Research
- Cancer, Lipids, and Metabolism
- Cancer Mechanisms and Therapy
- Ultrasound in Clinical Applications
- Lung Cancer Treatments and Mutations
- Liver physiology and pathology
- MRI in cancer diagnosis
- MicroRNA in disease regulation
- Gallbladder and Bile Duct Disorders
- Ultrasound Imaging and Elastography
- Radiomics and Machine Learning in Medical Imaging
- Liver Diseases and Immunity
- Cancer Immunotherapy and Biomarkers
- Gastric Cancer Management and Outcomes
- Cancer, Hypoxia, and Metabolism
- Renal cell carcinoma treatment
University of Bologna
2016-2025
Azienda USL di Bologna
2008-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2013-2024
Exact Sciences (United States)
2024
Siemens Healthcare (Germany)
2024
Bayer (United States)
2024
Sana Klinikum Lichtenberg
2024
University of Verona
2024
Ospedale per gli Infermi
2023-2024
Collaborative Group (United States)
2024
The technical part of these Guidelines and Recommendations, produced under the auspices EFSUMB, provides an introduction to physical principles technology on which all forms current commercially available ultrasound elastography are based. A difference in shear modulus is common underlying mechanism that tissue contrast elastograms. relationship between alternative technologies considered terms method used take advantage this. practical advantages disadvantages associated with each...
Thematic Section Chairperson 1 Introduction F. Piscaglia – C. Nolsøe 2 Generalities D. Cosgrove 3 Equipment H. P. Weskott 4 Investigator's training O. Gilja 5 Terminology 6 Safety G. ter Haar 7 Paediatric 8 Pancreas M. D'Onofrio 9 Endoscopic CEUS Dietrich 10 Gastrointestinal tract 11 Spleen Catalano 12 Kidney Bertolotto 13 Vesicoureteral reflux 14 Scrotum S. Sidhu 15 Abdominal Trauma 16 Lung and pleural lesions Mathis 17 Vascular Clevert 18 Cerebral vessels Seidel 19 Inflammatory joint...
The clinical part of these Guidelines and Recommendations produced under the auspices European Federation Societies for Ultrasound in Medicine Biology EFSUMB assesses clinically used applications all forms elastography, stressing evidence from meta-analyses giving practical advice their uses interpretation. Diffuse liver disease largest section, reflecting wide experience with transient shear wave elastography . Then follow breast, thyroid, gastro-intestinal tract, endoscopic prostate...
Abstract The updated version of the EFSUMB guidelines on application non-hepatic contrast-enhanced ultrasound (CEUS) deals with use microbubble contrast outside liver in many established and emerging applications.
Abstract We present here the first update of 2013 EFSUMB (European Federation Societies for Ultrasound in Medicine and Biology) Guidelines Recommendations on clinical use elastography, focused assessment diffuse liver disease. The part (long version) these deals with basic principles elastography provides an how technology has changed. practical advantages disadvantages associated each techniques are described, guidance is provided regarding optimization scanning technique, image display,...
Key words contrast agent - liver urinary v. ureteric reflux pancreas trauma transcranial US
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome and may evolve into hepatocellular carcinoma (HCC). Only scanty clinical information is available on HCC in NAFLD. The aim this multicenter observational prospective study was to assess features patients with NAFLD-related (NAFLD-HCC) compare them those hepatitis C virus (HCV)-related HCC. A total 756 either NAFLD (145) or HCV-related chronic (611) were enrolled secondary care Italian centers....
Initially, a set of guidelines for the use ultrasound contrast agents was published in 2004 dealing only with liver applications. A second edition 2008 reflected changes available and updated liver, as well implementing some non-liver Time has moved on, need international on CEUS become apparent. The present document describes third iteration recommendations hepatic enhanced (CEUS) using specific imaging techniques. This joint WFUMB-EFSUMB initiative implicated experts from major leading...
Abstract In a prospective study, we examined the impact of arterial hypervascularity, as established by European Association for Study Liver (EASL) recommendations, criterion characterizing small (1-3 cm) nodules in cirrhosis. A total 72 (1-2 cm, n = 41; 2.1-3 31) detected ultrasonography 59 patients with cirrhosis were included study. When coincidental hypervascularity was at contrast perfusional and helical computed tomography, lesion considered to be hepatocellular carcinoma (HCC)...
Abstract A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in arm, we conducted an observational adequately assess risks and this regimen field practice. Starting 2008, all clinically compensated HCC those intermediate who were unfit or failed respond ablative therapies consecutively evaluated six liver centers Italy,...
Abstract Dynamic Contrast Enhanced Ultrasound (DCE-US) is an imaging technique that utilizes microbubble contrast agents in diagnostic ultrasound. The EFSUMB guidelines published 2004, updated 2008 and 2011 focused on the use of DCE-US, including essential technical requirements, training, investigational procedures steps, guidance image interpretation, established recommended clinical indications safety considerations. However quantification images acquired with ultrasound (UCAs) not...
Abstract The updated version of the EFSUMB guidelines on application non-hepatic contrast-enhanced ultrasound (CEUS) deals with use microbubble contrast outside liver in many established and emerging applications.